Brief: Astrazeneca Pharma India March-Quarter PAT 448.8 Million Rupees
26/05/2026 15:31
BRIEF-Astrazeneca Pharma India March-Quarter PAT 448.8 Million Rupees May 26 (Reuters) - Astrazeneca Pharma India Ltd ASTR.NS:
ASTRAZENECA PHARMA INDIA LTD MARCH-QUARTER PAT 448.8 MILLION RUPEES
ASTRAZENECA PHARMA INDIA LTD MARCH-QUARTER REVENUE FROM OPERATIONS 5.79 BILLION RUPEES
Further company coverage: ASTR.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma India Receives Permission To Import And Sell Trastuzumab Deruxtecan For Additional Indication
Brief: Astrazeneca Pharma Says Bhavana Agrawal Resigns As CFO
Brief: Astrazeneca Pharma India Receives Permission To Import And Sell Benralizumab For Additional Indication
Brief: Astrazeneca Pharma India Receives Permission To Import Benralizumab (Fasenra) For Additional Indication
Brief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan